{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T18:30:59Z","timestamp":1783103459050,"version":"3.54.6"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100021802","name":"Department of Pathology and Laboratory Medicine, Weill Cornell Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021802","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","ajkd.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1053\/j.ajkd.2024.09.007","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T10:36:22Z","timestamp":1731580582000},"page":"353-363.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinicopathologic, Proteomic and Outcome Characteristics of Renal Apolipoprotein C-II Amyloidosis: A Case Series"],"prefix":"10.1053","volume":"85","author":[{"given":"Samih H.","family":"Nasr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surendra","family":"Dasari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony M.","family":"Valeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Theis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Moyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Buglioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Barry","family":"Stokes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Hasadsri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Vrana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar M.","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Kudose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraja","family":"Kambham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei Lin","family":"Bissonnette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renu","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attaya","family":"Suvannasankha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renuka","family":"Sothinathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adil","family":"Jadoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tewabe","family":"Kebede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srimathi","family":"Manickaratnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan L.","family":"Rosenstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen S.","family":"Markowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen D.","family":"McPhail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1053\/j.ajkd.2024.09.007_bib1","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.2215\/CJN.10491012","article-title":"Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases","volume":"8","author":"Said","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2024.09.007_bib2","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/ki.2014.11","article-title":"Clinical, morphologic, and genetic features of renal leukocyte chemotactic factor 2 amyloidosis","volume":"86","author":"Larsen","year":"2014","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.ajkd.2024.09.007_bib3","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1681\/ASN.2008060614","article-title":"Diagnosis, pathogenesis, treatment, and prognosis of hereditary fibrinogen A alpha-chain amyloidosis","volume":"20","author":"Gillmore","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2024.09.007_bib4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/978-3-319-17344-3_8","article-title":"Amyloid-forming properties of human apolipoproteins: sequence analyses and structural insights","volume":"855","author":"Das","year":"2015","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"10.1053\/j.ajkd.2024.09.007_bib5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1681\/ASN.2015111228","article-title":"Novel type of renal amyloidosis derived from apolipoprotein-CII","volume":"28","author":"Nasr","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2024.09.007_bib6","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.ekir.2018.04.009","article-title":"Apolipoprotein CII amyloidosis associated with p.Lys41Thr mutation","volume":"3","author":"Sethi","year":"2018","journal-title":"Kidney Int Rep"},{"issue":"1","key":"10.1053\/j.ajkd.2024.09.007_bib7","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/13506129.2018.1562442","article-title":"Hereditary systemic amyloidosis caused by K19T apolipoprotein C-II variant","volume":"26","author":"Liapis","year":"2019","journal-title":"Amyloid"},{"issue":"12","key":"10.1053\/j.ajkd.2024.09.007_bib8","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.3324\/haematol.2022.281431","article-title":"Mass spectrometry-based proteomics in clinical practice amyloid typing: state-of-the-art from a French nationwide cohort","volume":"107","author":"Colombat","year":"2022","journal-title":"Haematologica"},{"issue":"24","key":"10.1053\/j.ajkd.2024.09.007_bib9","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1182\/blood-2009-07-230722","article-title":"Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens","volume":"114","author":"Vrana","year":"2009","journal-title":"Blood"},{"issue":"9","key":"10.1053\/j.ajkd.2024.09.007_bib10","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.mayocp.2020.06.029","article-title":"Amyloid typing by mass spectrometry in clinical practice: a comprehensive review of 16,175 samples","volume":"95","author":"Dasari","year":"2020","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"10.1053\/j.ajkd.2024.09.007_bib11","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1021\/acs.jproteome.5b00015","article-title":"Proteomic detection of immunoglobulin light chain variable region peptides from amyloidosis patient biopsies","volume":"14","author":"Dasari","year":"2015","journal-title":"J\u00a0Proteome Res"},{"issue":"10","key":"10.1053\/j.ajkd.2024.09.007_bib12","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/jms.3264","article-title":"Shotgun-proteomics-based clinical testing for diagnosis and classification of amyloidosis","volume":"48","author":"Theis","year":"2013","journal-title":"J\u00a0Mass Spectrom"},{"issue":"5","key":"10.1053\/j.ajkd.2024.09.007_bib13","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1021\/pr4011475","article-title":"Clinical proteome informatics workbench detects pathogenic mutations in hereditary amyloidoses","volume":"13","author":"Dasari","year":"2014","journal-title":"J\u00a0Proteome Res"},{"issue":"5","key":"10.1053\/j.ajkd.2024.09.007_bib14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"19","key":"10.1053\/j.ajkd.2024.09.007_bib15","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1053\/j.ajkd.2024.09.007_bib16","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/ki.2013.558","article-title":"Characterization and outcomes of renal leukocyte chemotactic factor 2-associated amyloidosis","volume":"86","author":"Said","year":"2014","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ajkd.2024.09.007_bib17","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.ajpath.2011.06.024","article-title":"Amyloidogenicity and clinical phenotype associated with five novel mutations in apolipoprotein A-I","volume":"179","author":"Rowczenio","year":"2011","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1053\/j.ajkd.2024.09.007_bib18","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.kint.2016.04.003","article-title":"Clinical, biopsy, and mass spectrometry characteristics of renal apolipoprotein A-IV amyloidosis","volume":"90","author":"Dasari","year":"2016","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ajkd.2024.09.007_bib19","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.kint.2016.11.017","article-title":"Clinical, biopsy, and mass spectrometry findings of renal gelsolin amyloidosis","volume":"91","author":"Sethi","year":"2017","journal-title":"Kidney Int"},{"issue":"15","key":"10.1053\/j.ajkd.2024.09.007_bib20","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1182\/blood-2009-06-223792","article-title":"Hereditary fibrinogen A alpha-chain amyloidosis: phenotypic characterization of a systemic disease and the role of liver transplantation","volume":"115","author":"Stangou","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.ajkd.2024.09.007_bib21","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/ndt\/gfm684","article-title":"Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome","volume":"23","author":"Bergesio","year":"2008","journal-title":"Nephrol Dial Transplant"},{"issue":"13","key":"10.1053\/j.ajkd.2024.09.007_bib22","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance","volume":"354","author":"Kyle","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1053\/j.ajkd.2024.09.007_bib23","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/j.humpath.2007.04.013","article-title":"Clinical and histological characteristics of renal AA amyloidosis: a retrospective study of 68 cases with a special interest to amyloid-associated inflammatory response","volume":"38","author":"Verine","year":"2007","journal-title":"Hum Pathol"},{"issue":"4","key":"10.1053\/j.ajkd.2024.09.007_bib24","first-page":"416","article-title":"Leukocyte chemotactic factor 2 amyloidosis (ALECT2) is a\u00a0common form of renal amyloidosis among Egyptians","volume":"29","author":"Larsen","year":"2016","journal-title":"Mod\u00a0Pathol"},{"issue":"1","key":"10.1053\/j.ajkd.2024.09.007_bib25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.kint.2020.03.033","article-title":"New clinical forms of hereditary apoA-I amyloidosis entail both glomerular and retinal amyloidosis","volume":"98","author":"Colombat","year":"2020","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.ajkd.2024.09.007_bib26","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1369\/jhc.4A6387.2005","article-title":"Colocalization of apolipoprotein AI in various kinds of systemic amyloidosis","volume":"53","author":"Sakata","year":"2005","journal-title":"J\u00a0Histochem Cytochem"},{"issue":"1","key":"10.1053\/j.ajkd.2024.09.007_bib27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/13506129.2022.2120800","article-title":"Binding of serum-derived amyloid-associated proteins to amyloid fibrils","volume":"30","author":"Misumi","year":"2023","journal-title":"Amyloid"},{"key":"10.1053\/j.ajkd.2024.09.007_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10353","article-title":"D25V apolipoprotein C-III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profile","volume":"7","author":"Valleix","year":"2016","journal-title":"Nat Commun"},{"issue":"28","key":"10.1053\/j.ajkd.2024.09.007_bib29","doi-asserted-by":"crossref","first-page":"8276","DOI":"10.1021\/bi000002w","article-title":"Human apolipoprotein C-II forms twisted amyloid ribbons and closed loops","volume":"39","author":"Hatters","year":"2000","journal-title":"Biochemistry"},{"issue":"44","key":"10.1053\/j.ajkd.2024.09.007_bib30","doi-asserted-by":"crossref","first-page":"14762","DOI":"10.1039\/c0cp00299b","article-title":"Effects of mutation on the amyloidogenic propensity of apolipoprotein C-II(60-70) peptide","volume":"12","author":"Todorova","year":"2010","journal-title":"Phys Chem Chem Phys"},{"issue":"2","key":"10.1053\/j.ajkd.2024.09.007_bib31","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1172\/JCI112332","article-title":"Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients","volume":"77","author":"Baggio","year":"1986","journal-title":"J\u00a0Clin Invest"},{"key":"10.1053\/j.ajkd.2024.09.007_bib32","unstructured":"gnomAD browser. Date accessioned May 1, 2024. https:\/\/gnomad.broadinstitute.org\/variant\/19-44948767-A-C?dataset=gnomad_r4"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638624010540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638624010540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T05:21:23Z","timestamp":1742534483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638624010540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0272638624010540"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2024.09.007","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathologic, Proteomic and Outcome Characteristics of Renal Apolipoprotein C-II Amyloidosis: A Case Series","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2024.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}